<DOC>
	<DOC>NCT00131287</DOC>
	<brief_summary>The purpose of this study is to examine whether the extract of the Agaricus blazei Murill mushroom is effective in the supplementary treatment of type II DM patients.</brief_summary>
	<brief_title>The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)</brief_title>
	<detailed_description>The researchers have the animal model that the extract of the Agaricus blazei Murill mushroom is effective in the treatment of type II DM mice conducted on 2002. The dose effects were also found. The researchers conducted the pilot study also showing the same effects in 2003. So the researchers designed this trial. The elixir of the Agaricus blazei Murill mushroom is popular in Taiwan for chronic diseases, such as type II DM.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Type II DM Age 2075 years old Treat with Gliclazide and Metformin Signed informed consent GOT/GPT &gt;80/80 Creatinine &gt; 2.0 Lactating or pregnant women</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Agaricus Blazei Murill</keyword>
	<keyword>type II DM</keyword>
	<keyword>insulin index</keyword>
</DOC>